Release Date: 24/07/17 15:24 Summary: Appendix 4C - Quarterly Price Sensitive: No Download Document 359KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%